[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda, E
[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer]. [electronic resource] - Gan to kagaku ryoho. Cancer & chemotherapy Sep 1996 - 1291-8 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; English Abstract; Journal Article; Multicenter Study
0385-0684
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Colorectal Neoplasms--drug therapy
Drug Administration Schedule
Drug Combinations
Female
Humans
Male
Middle Aged
Mitomycin--administration & dosage
Prognosis
Survival Rate
Tegafur--administration & dosage
Uracil--administration & dosage
[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer]. [electronic resource] - Gan to kagaku ryoho. Cancer & chemotherapy Sep 1996 - 1291-8 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; English Abstract; Journal Article; Multicenter Study
0385-0684
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Colorectal Neoplasms--drug therapy
Drug Administration Schedule
Drug Combinations
Female
Humans
Male
Middle Aged
Mitomycin--administration & dosage
Prognosis
Survival Rate
Tegafur--administration & dosage
Uracil--administration & dosage